<table id="t7" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 8: Drug Interactions: Pharmacokinetic Parameters for Co-administered Drugs in the Presence of EDURANT</caption>
<col align="left" valign="top" width="22%"></col>
<col align="center" valign="top" width="15%"></col>
<col align="center" valign="top" width="15%"></col>
<col align="center" valign="top" width="6%"></col>
<col align="center" valign="top" width="14%"></col>
<col align="center" valign="top" width="14%"></col>
<col align="center" valign="top" width="14%"></col>
<thead>
<tr>
<th rowspan="2" stylecode="Lrule Rrule" valign="bottom">Co-administered Drug</th>
<th colspan="2" stylecode="Botrule Rrule" valign="bottom">Dose/Schedule</th>
<th rowspan="2" stylecode="Rrule" valign="bottom">N</th>
<th colspan="3" stylecode="Botrule Rrule" valign="bottom">Mean Ratio of <content stylecode="underline">Co-administered Drug</content>
<br/>Pharmacokinetic Parameters<br/>With/Without EDURANT<br/>(90% CI); No Effect = 1.00</th>
</tr>
<tr>
<th align="center" stylecode="Rrule" valign="bottom">Co-administered Drug</th>
<th stylecode="Rrule" valign="bottom">Rilpivirine</th>
<th stylecode="Rrule" valign="bottom">C<sub>max</sub>
</th>
<th stylecode="Rrule" valign="bottom">AUC</th>
<th stylecode="Rrule" valign="bottom">C<sub>min</sub>
</th>
</tr>
</thead>
<tfoot>
<tr>
<td align="left" colspan="7">CI = Confidence Interval; N = maximum number of subjects with data; N.A. = not available; ↑ = increase; ↓ = decrease; ↔ = no change; q.d. = once daily; b.i.d. = twice daily</td>
</tr>
</tfoot>
<tbody>
<tr stylecode="Botrule">
<td colspan="7" stylecode="Lrule Rrule">
<content stylecode="bold">Co-Administration With HIV Protease Inhibitors (PIs)</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Darunavir/ritonavir</td>
<td stylecode="Rrule">800/100 mg q.d.</td>
<td stylecode="Rrule">150 mg q.d.<footnote id="t7fn1">This interaction study has been performed with a dose higher than the recommended dose for EDURANT (25 mg once daily) assessing the maximal effect on the co-administered drug.</footnote>
</td>
<td stylecode="Rrule">15</td>
<td stylecode="Rrule">0.90<br/>(0.81–1.00)</td>
<td stylecode="Rrule">0.89<br/>(0.81–0.99)</td>
<td stylecode="Rrule">0.89<br/>(0.68–1.16)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Lopinavir/ritonavir<br/>(soft gel capsule)</td>
<td stylecode="Rrule">400/100 mg b.i.d.</td>
<td stylecode="Rrule">150 mg q.d.<footnoteref idref="t7fn1"></footnoteref>
</td>
<td stylecode="Rrule">15</td>
<td stylecode="Rrule">0.96<br/>(0.88–1.05)</td>
<td stylecode="Rrule">0.99<br/>(0.89–1.10)</td>
<td stylecode="Rrule">0.89<br/>(0.73–1.08)</td>
</tr>
<tr stylecode="Botrule">
<td colspan="7" stylecode="Lrule Rrule">
<content stylecode="bold">Co-Administration With HIV Nucleoside or Nucleotide Reverse Transcriptase Inhibitors (NRTIs/N[t]RTIs)</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Didanosine</td>
<td stylecode="Rrule">400 mg q.d.<br/>delayed release capsules taken 2 hours before rilpivirine</td>
<td stylecode="Rrule">150 mg q.d.<footnoteref idref="t7fn1"></footnoteref>
</td>
<td stylecode="Rrule">13</td>
<td stylecode="Rrule">0.96<br/>(0.80–1.14)</td>
<td stylecode="Rrule">1.12<br/>(0.99–1.27)</td>
<td stylecode="Rrule">N.A.</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Tenofovir disoproxil fumarate</td>
<td stylecode="Rrule">300 mg q.d.</td>
<td stylecode="Rrule">150 mg q.d.<footnoteref idref="t7fn1"></footnoteref>
</td>
<td stylecode="Rrule">16</td>
<td stylecode="Rrule">1.19<br/>(1.06–1.34)</td>
<td stylecode="Rrule">1.23<br/>(1.16–1.31)</td>
<td stylecode="Rrule">1.24<br/>(1.10–1.38)</td>
</tr>
<tr stylecode="Botrule">
<td colspan="7" stylecode="Lrule Rrule">
<content stylecode="bold">Co-Administration With HIV Integrase Strand Transfer Inhibitors</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Raltegravir</td>
<td stylecode="Rrule">400 mg b.i.d.</td>
<td stylecode="Rrule">25 mg q.d.</td>
<td stylecode="Rrule">23</td>
<td stylecode="Rrule">1.10<br/>(0.77–1.58)</td>
<td stylecode="Rrule">1.09<br/>(0.81–1.47)</td>
<td stylecode="Rrule">1.27<br/>(1.01–1.60)</td>
</tr>
<tr stylecode="Botrule">
<td colspan="7" stylecode="Lrule Rrule">
<content stylecode="bold">Co-Administration With other Antivirals</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Telaprevir</td>
<td stylecode="Rrule">750 mg q8h</td>
<td stylecode="Rrule">25 mg q.d.</td>
<td stylecode="Rrule">13</td>
<td stylecode="Rrule">0.97<br/>(0.79–1.21)</td>
<td stylecode="Rrule">0.95<br/>(0.76–1.18)</td>
<td stylecode="Rrule">0.89<br/>(0.67–1.18)</td>
</tr>
<tr stylecode="Botrule">
<td colspan="7" stylecode="Lrule Rrule">
<content stylecode="bold">Co-Administration With Drugs other than Antiretrovirals</content>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Acetaminophen</td>
<td stylecode="Rrule">500 mg single dose</td>
<td stylecode="Rrule">150 mg q.d.<footnoteref idref="t7fn1"></footnoteref>
</td>
<td stylecode="Rrule">16</td>
<td stylecode="Rrule">0.97<br/>(0.86–1.10)</td>
<td stylecode="Rrule">0.91<br/>(0.86–0.97)</td>
<td stylecode="Rrule">N.A.</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Atorvastatin</td>
<td stylecode="Rrule">40 mg q.d.</td>
<td stylecode="Rrule">150 mg q.d.<footnoteref idref="t7fn1"></footnoteref>
</td>
<td stylecode="Rrule">16</td>
<td stylecode="Rrule">1.35<br/>(1.08–1.68)</td>
<td stylecode="Rrule">1.04<br/>(0.97–1.12)</td>
<td stylecode="Rrule">0.85<br/>(0.69–1.03)<br/>
<br/>
</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">2-hydroxy-atorvastatin</td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule">16</td>
<td stylecode="Rrule">1.58<br/>(1.33–1.87)</td>
<td stylecode="Rrule">1.39<br/>(1.29–1.50)</td>
<td stylecode="Rrule">1.32<br/>(1.10–1.58)<br/>
<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">4-hydroxy-atorvastatin</td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule">16</td>
<td stylecode="Rrule">1.28<br/>(1.15–1.43)</td>
<td stylecode="Rrule">1.23<br/>(1.13–1.33)</td>
<td stylecode="Rrule">N.A.</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Chlorzoxazone</td>
<td stylecode="Rrule">500 mg single dose taken 2 hours after rilpivirine</td>
<td stylecode="Rrule">150 mg q.d.<footnoteref idref="t7fn1"></footnoteref>
</td>
<td stylecode="Rrule">16</td>
<td stylecode="Rrule">0.98<br/>(0.85–1.13)</td>
<td stylecode="Rrule">1.03<br/>(0.95–1.13)</td>
<td stylecode="Rrule">N.A.</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Digoxin</td>
<td stylecode="Rrule">0.5 mg single dose</td>
<td stylecode="Rrule">25 mg q.d. </td>
<td stylecode="Rrule">22</td>
<td stylecode="Rrule">1.06<br/>(0.97–1.17)</td>
<td stylecode="Rrule">0.98<br/>(0.93–1.04)<footnote id="t7fn2">AUC<sub>(0–last)</sub>
</footnote>
</td>
<td stylecode="Rrule">N.A.</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Ethinylestradiol</td>
<td stylecode="Rrule">0.035 mg q.d.</td>
<td stylecode="Rrule">25 mg q.d.</td>
<td stylecode="Rrule">17</td>
<td stylecode="Rrule">1.17<br/>(1.06–1.30)</td>
<td stylecode="Rrule">1.14<br/>(1.10–1.19)</td>
<td stylecode="Rrule">1.09<br/>(1.03–1.16)<br/>
<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Norethindrone</td>
<td stylecode="Rrule">1 mg q.d.</td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule">17</td>
<td stylecode="Rrule">0.94<br/>(0.83–1.06)</td>
<td stylecode="Rrule">0.89<br/>(0.84–0.94)</td>
<td stylecode="Rrule">0.99<br/>(0.90–1.08)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Ketoconazole</td>
<td stylecode="Rrule">400 mg q.d.</td>
<td stylecode="Rrule">150 mg q.d.<footnoteref idref="t7fn1"></footnoteref>
</td>
<td stylecode="Rrule">14</td>
<td stylecode="Rrule">0.85<br/>(0.80–0.90)</td>
<td stylecode="Rrule">0.76<br/>(0.70–0.82)</td>
<td stylecode="Rrule">0.34<br/>(0.25–0.46)</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">R(-) methadone</td>
<td stylecode="Rrule">60–100 mg q.d., individualised dose</td>
<td stylecode="Rrule">25 mg q.d.</td>
<td stylecode="Rrule">13</td>
<td stylecode="Rrule">0.86<br/>(0.78–0.95)</td>
<td stylecode="Rrule">0.84<br/>(0.74–0.95)</td>
<td stylecode="Rrule">0.78<br/>(0.67–0.91)<br/>
<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">S(+) methadone</td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule">13</td>
<td stylecode="Rrule">0.87<br/>(0.78–0.97)</td>
<td stylecode="Rrule">0.84<br/>(0.74–0.96)</td>
<td stylecode="Rrule">0.79<br/>(0.67–0.92)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Metformin</td>
<td stylecode="Rrule">850 mg single dose</td>
<td stylecode="Rrule">25 mg q.d.</td>
<td stylecode="Rrule">20</td>
<td stylecode="Rrule">1.02<br/>(0.95–1.10)</td>
<td stylecode="Rrule">0.97<br/>(0.90–1.06)<footnote>N (maximum number of subjects with data) for AUC<sub>(0–∞) </sub>= 15</footnote>
</td>
<td stylecode="Rrule">N.A.</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Omeprazole</td>
<td stylecode="Rrule">20 mg q.d.</td>
<td stylecode="Rrule">150 mg q.d.<footnoteref idref="t7fn1"></footnoteref>
</td>
<td stylecode="Rrule">15</td>
<td stylecode="Rrule">0.86<br/>(0.68–1.09)</td>
<td stylecode="Rrule">0.86<br/>(0.76–0.97)</td>
<td stylecode="Rrule">N.A.</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Rifampin</td>
<td stylecode="Rrule">600 mg q.d.</td>
<td stylecode="Rrule">150 mg q.d.<footnoteref idref="t7fn1"></footnoteref>
</td>
<td stylecode="Rrule">16</td>
<td stylecode="Rrule">1.02<br/>(0.93–1.12)<br/> </td>
<td stylecode="Rrule">0.99<br/>(0.92–1.07)</td>
<td stylecode="Rrule">N.A.<br/>
<br/>
</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">25-desacetylrifampin</td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule">16</td>
<td stylecode="Rrule">1.00<br/>(0.87–1.15)</td>
<td stylecode="Rrule">0.91<br/>(0.77–1.07)</td>
<td stylecode="Rrule">N.A.</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Sildenafil</td>
<td stylecode="Rrule">50 mg single dose</td>
<td stylecode="Rrule">75 mg q.d.<footnoteref idref="t7fn1"></footnoteref>
</td>
<td stylecode="Rrule">16</td>
<td stylecode="Rrule">0.93<br/>(0.80–1.08)<br/> </td>
<td stylecode="Rrule">0.97<br/>(0.87–1.08)</td>
<td stylecode="Rrule">N.A.<br/>
<br/>
</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">
<content stylecode="italics">N</content>-desmethyl-sildenafil</td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule"></td>
<td stylecode="Rrule">16</td>
<td stylecode="Rrule">0.90<br/>(0.80–1.02)</td>
<td stylecode="Rrule">0.92<br/>(0.85–0.99)<footnoteref idref="t7fn2"></footnoteref>
</td>
<td stylecode="Rrule">N.A.</td>
</tr>
</tbody>
</table>